Sector: Pharmaceutical Preparations · Industry: Drug Manufacturers - General · Exchange: NYSE
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
Headquarters: Rahway, NJ · Employees: 73000 · Website: https://www.merck.com
Merck & Co., Inc. (MRK) is a publicly traded company in the Pharmaceutical Preparations sector (Drug Manufacturers - General), listed on NYSE. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Macroplane tracks Merck & Co., Inc.'s (MRK) supply chain. Key suppliers include IQVIA HOLDINGS INC. (IQV), Cencora, Inc. (COR), BIO-TECHNE Corp (TECH), 10x Genomics, Inc. (TXG), WATERS CORP /DE/ (WAT), Guardant Health, Inc. (GH), WEST PHARMACEUTICAL SERVICES INC (WST), VEEVA SYSTEMS INC (VEEV), and 1 more. Key customers include Accenture plc (ACN), COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH).
Competitors of Merck & Co., Inc. (MRK) tracked by Macroplane include ELI LILLY & Co (LLY), JOHNSON & JOHNSON (JNJ), AbbVie Inc. (ABBV), NOVO NORDISK A S (NVO), AMGEN INC (AMGN), PFIZER INC (PFE), Bayer Aktiengesellschaft (1BAYN.MI), IQVIA HOLDINGS INC. (IQV), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets